Luca De Fiore @lucadf X Profile

Luca De Fiore

@lucadf

Followers

2K

Following

16K

Media

2K

Statuses

14K

Publisher @IlPensiero @RecentiProgMed | @forwardRPM | past president Italian Cochrane network | @EASEeditors Italian chapter

https://t.co/BPnHUdAjFz

Rome, Italy

Joined March 2009

Don't wanna be here? Send us removal request.

OncoDaily

@oncodaily

7 months

The role of social media in fueling bias in oncology - Raffaele Giusti @oncoblogger @JAMAOnc @fotiosloupakis https://t.co/goZjq7tOrZ #Cancer #CancerResearch #Medicine #Health #AI #DigitalHealth #FCOI #MedX #MedNews #MedEd #SocialMedia #Oncology #OncoDaily

2

15

Luca De Fiore

@lucadf

7 months

N

0

1

Retraction Watch

@RetractionWatch

8 months

“Paths to Full Open Access for Cochrane Reviews.” https://t.co/Jt6cGGi23k

0

3

12

Luca De Fiore

@lucadf

9 months

L’affaire #USAID: aiutare chi ha bisogno è nel nostro interesse. La scelta scellerata di Donald Trump va contro l’interesse anche dei cittadini statunitensi: ridurre le disuguaglianze rende il mondo più sicuro, oltre che meno iniquo. @careonlineit https://t.co/3TRLUojCqw

0

2

5

Publishing with Integrity

@fake_journals

11 months

In the world of unethical publishing there are many elephants in the room. What's yours? I'll go first. It's the fact that there is no universally agreed definition of predatory publishing, yet people ask all the time, "Is this journal predatory?" Sometimes it is obvious it

2

4

8

Publishing with Integrity

@fake_journals

11 months

Just looking at the articles that have been published this year. Top of the pile is @Nature's @SciReports. As of 19 Dec 2024, the journal has published 30,447 (more than 80 every day). Their #APC is USD $2,590, so the revenue generated by this journal is USD $78,857,739. There

8

24

76

Sir Michael Marmot

@MichaelMarmot

11 months

New @MarmotIHE report concludes twin crisis of #healthequity and #housing must be solved together by the property sector, central and local government building good quality houses in the right place, for the right people at the right price @petegladwell https://t.co/PTTN7RA92E

1

28

56

Eric Topol

@EricTopol

11 months

Open-access @bmj_latest

1

10

40

Florian Louis

@flr_louis

1 year

La leçon de Marc Bloch, une conversation avec Carlo Ginzburg

legrandcontinent.eu

Marc Bloch entrera au Panthéon. Il y a 80 ans, Marc Bloch était exécuté par la Gestapo. Dans un entretien lumineux en forme d’hommage, Carlo Ginzburg témoigne de l’apport considérable de l’auteur des...

2

153

378

Luca De Fiore

@lucadf

11 months

“We need a healthcare workforce that sees individuals dealing with their illnesses within their wider socioeconomic, sociocultural, and environmental contexts.”

The BMJ

@bmj_latest

11 months

How we train future clinicians has the potential to radically and sustainably improve healthcare for everyone. Medical education fit for the future requires radical change #MedEd https://t.co/xnbhmfqBJ6

0

1

4

Oncoinfo

@Oncoinfo_it

11 months

#SABCS24 | Sebbene diagnosi precoce e screening sembrino cosa buona in assoluto, il loro rapporto rischio-beneficio per i #BC non è così scontato. Diagnosi e trattamento più precoci non sempre hanno un effetto benefico sulla mortalità. https://t.co/fX1Tniyr9T @lucadf

oncoinfo.it

Dobbiamo abbandonare la rilevazione del tumore come endpoint surrogato negli studi di screening.

0

1

4

Luca De Fiore

@lucadf

11 months

Anche quest’anno ha vinto la migliore. Una (piccola, forse, ma non tanto) buonq notizia. Bravissima @sbencivu

CNR Consiglio Nazionale delle Ricerche

@CNRsocial_

11 months

Vince la XXII edizione del @PremioDivScient, Silvia Bencivelli con 'Eroica, folle e visionaria' (@BBEditore) Congratulazioni alla vincitrice e complimenti a tutti gli autori e le autrici! Al prossimo anno...

1

0

4

Luca De Fiore

@lucadf

1 year

Incertezza sull’efficacia e sicurezza dei farmaci? Ovvio, spiega Patrizia Popoli. 💊 dati incompleti 💊 mancanza di studi comparativi 💊 eventuali studi di confronto con placebo o non con il gold standard

0

1

8

Luca De Fiore

@lucadf

1 year

Che confusione, dice @genazzani a @SIFaCTmedia Le decisioni di @FDA @EMA_News e @Aifa_ufficiale solo raramente sono coerenti tra loro. Ma il lavoro regolatorio è essenziale…

0

1

4

Luca De Fiore

@lucadf

1 year

Accelerare i tempi di approvazione dei farmaci vuol dire ridurre il rigore dei criteri di valutazione. Giuseppe Traversa al congresso 2024 @SIFaCTmedia

0

1

8

Associali - Cochrane Affiliate Centre

@associali

1 year

LE LINEE GUIDA PER LA PRATICA CLINICA IN ITALIA Il 28 novembre è in programma a Firenze #associali24. L'incontro si aprirà con una lectio magistralis di @marge_reinap. Guarda il programma completo e iscriviti: https://t.co/CBLNQzgEix

0

6

7

Publishing with Integrity

@fake_journals

1 year

Apart from being a very interesting, and pertinent, article, the fact that it is written by a stellar line up on sleuths who collabortaed on this article, just adds to its attraction. | @JAByrneSci | @AbalkinaAnna | @Image_Integrity | @DrSarahEaton | @nickwizzo |

0

11

38

Luca De Fiore

@lucadf

1 year

This is a manifesto for living a happy life. 👏🏻

Adam Cifu

@adamcifu

1 year

Coming Out Against the Healthy Lifestyle https://t.co/lL9iF0nVzG

0

2

Luca De Fiore

@lucadf

1 year

… so I need to share your post among the friends in this “common intl res community”, such as @GrimshawJeremy @Richard56 @VincentRK @vmontori @richardhorton1 @schunemann_mac @KarstenJuhl @jpkassirer … and many others, luckily ☺️

Dario Trapani

@darioT_

1 year

"Alessandro..encouraged to research, challenge, think radically..infused us with a sense of belonging to a common international research community engaged in promoting #solidarity & #progress in major public health issues @csoncol

3

4

7

Rebecca De Fiore

@RebeccaDeFiore

1 year

🔸 Le linee guida per la pratica clinica in Italia: dalla produzione all’applicazione Le domande aperte sono tante e bisogna discuterne insieme. Ci vediamo a Firenze? Registrati qui: https://t.co/BQzCdICADb #associali24

0

3

5